Hepion shareholders reject authorized share increase from 120M to 200M

Hepion Pharmaceuticals, Inc.

Proposal received 19,267,720 For, 27,847,827 Against, 254,176 Abstain; broker non-votes 1.
The amendment to the certificate of incorporation was not approved.
Meeting was previously adjourned to complete voting on this proposal.

item 5.07

Hepion Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-086685

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.